Clinical Trials Directory

Trials / Unknown

UnknownNCT05364710

Clinical Proof-of-concept Study on Rapid Immune Modulating Effects

Clinical Poof-of-concept Study on Rapid Immune Modulating Effects

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Natural Immune Systems Inc · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Clinical-proof-of concept study, comparing the acute immune impacts of of 2 doses of a novel blend of supplements to a placebo. This study involves twenty-four participants, composed of healthy adults, who will be taking a placebo and 2 different doses of the blend at different times. Testing for immune status and cytokine levels will be conducted to determine the acute impact of the blend on immune function as compared to the placebo.

Detailed description

Clinical-proof-of-concept study comparing the acute immune effects of 2 doses of a nutraceutical blend, and a placebo. The nutraceutical blend is based on a transfer factor isolated from cow colostrum ultrafiltrate. 24 subjects will participate in a placebo-controlled, randomized, double-blinded, cross-over study design, wherein they will be taking placebo, dose 1, and dose 2, each separated by a 1-week washout period. Blood samples are taken 1 hour after participants arrive; the dose is then administered. Samples are taken 1 hour, 2 hours, and 24 hours following administration. At each blood sample collection, a spit sample will also be taken for salivary IgA testing. A series of immune panels will be used to determine the acute impacts on immune surveillance, immune cell activation status, immune cell priming, and cytokine profiles.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTransfer factor from colostrum ultrafiltrateProteins that confer immune protection, isolated from cow colostrum ultrafiltrate and used to promote immune health and surveillance.

Timeline

Start date
2022-05-07
Primary completion
2022-12-01
Completion
2023-06-01
First posted
2022-05-06
Last updated
2022-05-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05364710. Inclusion in this directory is not an endorsement.